Literature DB >> 23276969

Regulation of hepatocarcinogenesis by microRNAs.

Chun-Ming Wong1, Alan Ka-Lun Kai, Felice Ho-Ching Tsang, Irene Oi-Lin Ng.   

Abstract

Liver cancer (hepatocellular carcinoma, HCC) is a major malignancy worldwide. Etiologically, hepatocarcinogenesis is closely associated with HBV and HCV infections; however, its underlying molecular mechanism is not completely understood. MicroRNAs are a class of small non-coding RNAs that negatively regulate gene expression by interacting with the 3'UTR of protein-coding mRNA. MicroRNAs are implicated in nearly all major biological and cellular events, and recent findings further link microRNA deregulation to human carcinogenesis. In this review, we will focus on the aberrant expression of miRNAs in liver cancer and the pathological implications and molecular functions of some well-characterized oncogenic and tumor suppressive miRNAs. Finally, the clinical prospect of miRNAs as a novel diagnostic and therapeutic intervention will be discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23276969     DOI: 10.2741/e595

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  17 in total

1.  MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.

Authors:  Felice Ho-Ching Tsang; Sandy Leung-Kuen Au; Lai Wei; Dorothy Ngo-Yin Fan; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

Review 2.  Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.

Authors:  Chun-Ming Wong; Felice Ho-Ching Tsang; Irene Oi-Lin Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-10       Impact factor: 46.802

3.  miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.

Authors:  Zhong-Di Xiao; Chun-Yu Jiao; Hai-Tao Huang; Li-Jia He; Jiu-Jun Zhao; Zhao-Yang Lu; Lian-Xin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Bioinformatic analysis of microRNA networks following the activation of the constitutive androstane receptor (CAR) in mouse liver.

Authors:  Ruixin Hao; Shengzhong Su; Yinan Wan; Frank Shen; Ben Niu; Denise M Coslo; Istvan Albert; Xing Han; Curtis J Omiecinski
Journal:  Biochim Biophys Acta       Date:  2016-04-11

5.  Evidence for and against epithelial-to-mesenchymal transition in the liver.

Authors:  Guanhua Xie; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-24       Impact factor: 4.052

6.  MicroRNA-302d downregulates TGFBR2 expression and promotes hepatocellular carcinoma growth and invasion.

Authors:  Yue-Liang Chen; Qiu-Ping Xu; Feng Guo; Wen-Hua Guan
Journal:  Exp Ther Med       Date:  2016-12-13       Impact factor: 2.447

7.  Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.

Authors:  Felice H Tsang; Victor Au; Wen-Jing Lu; Felix H Shek; Angela M Liu; John M Luk; Sheung-Tat Fan; Ronnie T P Poon; Nikki P Lee
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

8.  MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops.

Authors:  Hua Wang; Bin Gao
Journal:  Hepatology       Date:  2014-09-29       Impact factor: 17.425

Review 9.  Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship.

Authors:  Denada Dibra; Lopa Mishra; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-05-09

10.  Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.

Authors:  Ming-De Huang; Wen-Ming Chen; Fu-Zhen Qi; Ming Sun; Tong-Peng Xu; Pei Ma; Yong-Qian Shu
Journal:  Mol Cancer       Date:  2015-09-04       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.